Clinical Social Workers in Healdsburg, CA Accepting Medicare

8 Clinical Social Workers found. Showing 1 - 8

Mrs. Ana Maria Halstad, L.C.S.W Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1381 Unversirty Ave, Healdsburg, CA 95488 Phone: 707-391-1944

Maria Guadalupe Juarez Sanchez, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1381 University St, Healdsburg, CA 95448 Phone: 707-433-5494    Fax: 707-385-2157

Amy Carolina Zenteno, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1381 University St, Healdsburg, CA 95448 Phone: 707-433-5494

Stacy Nicolle Fekkers, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1310 Prentice Dr Ste A, Healdsburg, CA 95448 Phone: 707-473-8445

Keith Enders, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1375 University Avenue, Healdsburg, CA 95448 Phone: 707-431-6500

Mrs. Laura Kathleen Capinas, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 411 East St, Healdsburg, CA 95448 Phone: 707-478-5552

Cynthia L Mattson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 141 North St Ste C, Healdsburg, CA 95448 Phone: 707-535-6835

Ms. Kathleen Ann Murphy, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 411 East St, Healdsburg, CA 95448 Phone: 707-431-7888

News Archive

AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA

AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).

New tool to expedite research ethics review during emergency preparedness

A new emergency review tool will help research ethics boards and institutions to expedite research while respecting the procedures of ethics reviews, states an article in CMAJ.

Experts address fundamental questions related to renal failure in ICU

Despite the fact that recent medical advances have allowed healthcare professionals to stabilize patients who would have otherwise died, many stabilized patients later develop organ system failure. In fact, acute renal failure is one of the biggest threats to critically ill patients: forty percent of patients with this condition die.

Several causes for concern regarding children's health in general practice in Britain

An editorial in this weeks BMJ highlights several causes for concern regarding children's health in general practice in Britain. Once greatly admired, the British model of general practice raises concern over the future of children's health.

Read more Medical News

› Verified 1 days ago